Cell death/apoptosis: normal, chemically induced, and teratogenic effect

Z F Zakeri1, H S Ahuja

  • 1Queens College and Graduate Center, Department of Biology, City University of New York, Flushing 11367-1597, USA.

Mutation Research
|January 22, 1998
PubMed

Insights

Programmed cell death is crucial for normal development. In mouse limb studies, retinoic acid corrected a genetic defect by enhancing cell death, suggesting therapeutic potential.

Area of Science:

  • Developmental Biology
  • Genetics
  • Cell Biology

Background:

  • Cell death, often termed programmed cell death, is essential for development, tissue patterning, and function.
  • Dysregulation of cell death contributes to disorders like cancer and teratogenesis.
  • Genetic control of cell death is critical, with specific genes identified.

Purpose of the Study:

  • To investigate the mechanisms and genetic basis of cell death during normal and abnormal development.
  • To elucidate the role of cell death in mouse limb development.
  • To explore the effects of teratogens on cell death and potential phenotypic correction.

Main Methods:

  • Utilized the developing mouse limb as a model system for studying cell death.
  • Developed markers to identify apoptotic morphology, phagocytosis, and DNA fragmentation.
  • Administered the teratogen retinoic acid to assess its impact on cell death patterns.

Main Results:

  • Confirmed apoptotic morphology with phagocytosis and DNA fragmentation in normal developing limbs.
  • Observed restricted cell death patterns in the Hammertoe limb deformity mutant.
  • Retinoic acid treatment enhanced apoptotic cell death in the mutant limb.
  • Retinoic acid-induced cell death corrected the phenotypic defect in the Hammertoe mutant.

Conclusions:

  • Programmed cell death is a genetically regulated process vital for normal development.
  • The developing mouse limb serves as a valuable model for studying cell death mechanisms.
  • Exogenous agents like retinoic acid can modulate cell death and potentially ameliorate genetic abnormalities.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...